Serono, Inc. Seeks Withdrawal of FDA Approval for Breokinase

Summary

Serono, Inc. has requested the FDA to withdraw its approval of a new drug application for Breokinase, a urokinase injection, due to the company's decision not to introduce the drug into the US market or export it from the US.